Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
31.43 (USD) • At close January 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 787.647 | 587 | 810 | 729 | 1,123 | 599.674 | 507.666 | 346.62 | 283.703 | 214.161 | 147.285 | 102.049 | 99.086 | 108.473 | 121.6 | 107.19 | 69.621 | 24.532 | 40.133 | 42.624 | 49.99 | 80.179 | 53.273 | 37.255 | 33.9 | 39.2 | 32.5 | 22.6 | 13 | 10.1 | 12.1 | 8.7 | 6.3 | 2 |
| Cost of Revenue
| 9.133 | 14 | 11 | 12 | 4 | 1.82 | 374.644 | 344.32 | 322.292 | 241.751 | 184.033 | 158.458 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.535 | -5.2 | -4.3 | -3.2 | -2.6 | -2.8 | -3.8 | 22.4 | -2 | 11.5 | 4.4 |
| Gross Profit
| 778.514 | 573 | 799 | 717 | 1,119 | 597.854 | 133.022 | 2.3 | -38.589 | -27.59 | -36.748 | -56.409 | 99.086 | 108.473 | 121.6 | 107.19 | 69.621 | 24.532 | 40.133 | 42.624 | 49.99 | 80.179 | 53.273 | 42.79 | 39.1 | 43.5 | 35.7 | 25.2 | 15.8 | 13.9 | -10.3 | 10.7 | -5.2 | -2.4 |
| Gross Profit Ratio
| 0.988 | 0.976 | 0.986 | 0.984 | 0.996 | 0.997 | 0.262 | 0.007 | -0.136 | -0.129 | -0.25 | -0.553 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.149 | 1.153 | 1.11 | 1.098 | 1.115 | 1.215 | 1.376 | -0.851 | 1.23 | -0.825 | -1.2 |
| Reseach & Development Expenses
| 899.625 | 833 | 643 | 535 | 466 | 414.604 | 374.644 | 344.32 | 322.292 | 241.751 | 184.033 | 158.458 | 157.397 | 145.16 | 134.623 | 106.439 | 92.641 | 80.567 | 82.467 | 118.474 | 116.963 | 124.074 | 83.741 | 57.014 | 66.4 | 62.2 | 55.9 | 45.7 | 33.2 | 26.5 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 232.6 | 150.3 | 170.9 | 354 | 287 | 244.622 | 108.488 | 48.616 | 37.173 | 20.14 | 14.918 | 12.515 | 12.789 | 11.669 | 14.515 | 13.811 | 0 | 0 | 8.432 | 9.582 | 9.289 | 8.547 | 11.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0.7 | 15.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.544 | -0.006 | 0.913 | -3.002 | 4.573 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 232.6 | 151 | 186 | 354 | 287 | 244.622 | 108.488 | 48.616 | 37.173 | 20.14 | 14.918 | 12.515 | 12.789 | 11.669 | 14.515 | 13.811 | 15.928 | 12.619 | 7.888 | 9.576 | 10.202 | 5.545 | 15.634 | 9.231 | 10.6 | 9.5 | 8.1 | 6.2 | 5.4 | 6 | 4.8 | 30.3 | 4.4 | 1.7 |
| Other Expenses
| 0 | 3 | 9 | 2 | -0.686 | -0.182 | -3.548 | 18.422 | 40.932 | 39.237 | 39.839 | 59.358 | 61.207 | 42.239 | 26.492 | 7.586 | 59.045 | 64.94 | 60.273 | 118.278 | 70.212 | 54.625 | 47.918 | 5.535 | 5.2 | 4.3 | 3.2 | 2.6 | 2.8 | 3.9 | 3.2 | 2 | 0.9 | 0.4 |
| Operating Expenses
| 1,132.244 | 984 | 829 | 889 | 753 | 659.226 | 483.132 | 392.936 | 359.465 | 261.891 | 198.951 | 170.973 | 170.186 | 156.829 | 149.138 | 120.25 | 108.569 | 93.186 | 90.355 | 128.05 | 127.165 | 129.619 | 99.375 | 71.78 | 82.2 | 76 | 67.2 | 54.5 | 41.4 | 36.4 | 8 | 32.3 | 5.3 | 2.1 |
| Operating Income
| -353.73 | -411 | -30 | -172 | 366 | -61.372 | 24.534 | -46.316 | -75.762 | -47.73 | -51.666 | -68.924 | -71.1 | -48.356 | -27.538 | -13.06 | -38.948 | -68.118 | -57.182 | -117.853 | -78.978 | -50.813 | -46.102 | -28.99 | -43.1 | -32.5 | -31.5 | -29.3 | -25.6 | -22.5 | -18.3 | -21.6 | -10.5 | -4.5 |
| Operating Income Ratio
| -0.449 | -0.7 | -0.037 | -0.236 | 0.326 | -0.102 | 0.048 | -0.134 | -0.267 | -0.223 | -0.351 | -0.675 | -0.718 | -0.446 | -0.226 | -0.122 | -0.559 | -2.777 | -1.425 | -2.765 | -1.58 | -0.634 | -0.865 | -0.778 | -1.271 | -0.829 | -0.969 | -1.296 | -1.969 | -2.228 | -1.512 | -2.483 | -1.667 | -2.25 |
| Total Other Income Expenses Net
| 19.765 | 152.206 | 1.038 | 37.53 | -27.117 | -14.784 | -47.81 | -37.306 | -12.144 | -6.661 | -14.892 | -5.663 | -13.69 | -12.803 | -4.227 | -0.965 | 27.954 | -3.706 | -15.219 | -24.65 | -16.018 | -21.429 | -27.73 | -17.859 | -7.2 | -1 | 3.9 | 3.8 | 3 | 5.5 | 0 | 2.1 | 1.8 | 0 |
| Income Before Tax
| -333.965 | -258 | -30 | -170 | 347 | -76.156 | -23.276 | -83.622 | -87.906 | -54.391 | -66.558 | -74.587 | -84.79 | -61.159 | -31.765 | -14.025 | -10.994 | -65.319 | -72.401 | -142.503 | -94.996 | -72.242 | -73.832 | -46.849 | -50.3 | -33.5 | -27.4 | -25.3 | -22.6 | -17 | 0 | -19.5 | -8.7 | 0 |
| Income Before Tax Ratio
| -0.424 | -0.44 | -0.037 | -0.233 | 0.309 | -0.127 | -0.046 | -0.241 | -0.31 | -0.254 | -0.452 | -0.731 | -0.856 | -0.564 | -0.261 | -0.131 | -0.158 | -2.663 | -1.804 | -3.343 | -1.9 | -0.901 | -1.386 | -1.258 | -1.484 | -0.855 | -0.843 | -1.119 | -1.738 | -1.683 | 0 | -2.241 | -1.381 | 0 |
| Income Tax Expense
| 32.321 | 12 | -1 | 317 | 44 | -291.141 | -5.98 | 2.934 | 0.372 | -15.407 | -5.914 | -9.109 | 0.011 | 0.092 | 3.191 | -1.097 | -27.954 | -22.751 | 22.179 | 57.077 | 17.821 | 6.791 | 8.89 | 24.495 | 16.1 | 10.5 | -0.4 | -2.8 | -1.9 | -4.3 | 0.8 | -2.1 | -1.8 | 0 |
| Net Income
| -366.286 | -270 | -29 | -487 | 294 | 273.741 | -5.97 | -86.556 | -88.278 | -38.984 | -60.644 | -65.478 | -84.801 | -61.251 | 155.066 | -11.963 | -10.994 | -45.903 | -72.401 | -142.503 | -94.996 | -72.242 | -73.832 | -53.485 | -59.2 | -43 | -31.1 | -26.5 | -23.7 | -18.2 | -19.1 | -19.5 | -8.7 | -4.5 |
| Net Income Ratio
| -0.465 | -0.46 | -0.036 | -0.668 | 0.262 | 0.456 | -0.012 | -0.25 | -0.311 | -0.182 | -0.412 | -0.642 | -0.856 | -0.565 | 1.275 | -0.112 | -0.158 | -1.871 | -1.804 | -3.343 | -1.9 | -0.901 | -1.386 | -1.436 | -1.746 | -1.097 | -0.957 | -1.173 | -1.823 | -1.802 | -1.579 | -2.241 | -1.381 | -2.25 |
| EPS
| -2.56 | -1.9 | -0.21 | -3.49 | 2.1 | 2.07 | -0.048 | -0.72 | -0.74 | -0.33 | -0.55 | -0.65 | -0.85 | -0.62 | 1.58 | -0.13 | -0.13 | -0.62 | -1.15 | -2.52 | -1.71 | -1.33 | -1.67 | -1.44 | -2.06 | -1.6 | -1.17 | -1.04 | -1.1 | -0.93 | -1.22 | -1.51 | -0.84 | -0.7 |
| EPS Diluted
| -2.56 | -1.9 | -0.21 | -3.49 | 2.06 | 2.04 | -0.047 | -0.72 | -0.74 | -0.33 | -0.55 | -0.65 | -0.85 | -0.62 | 1.58 | -0.13 | -0.13 | -0.62 | -1.15 | -2.52 | -1.71 | -1.33 | -1.67 | -1.44 | -2.06 | -1.6 | -1.17 | -1.04 | -1.1 | -0.93 | -1.22 | -1.51 | -0.84 | -0.7 |
| EBITDA
| -230.01 | -227.758 | -0.239 | -107.882 | 411.531 | -18.839 | 39.796 | -8.827 | -40.936 | -22.778 | -37.421 | -42.68 | -56.274 | -38.75 | -9.79 | 4.11 | -26.154 | -64.237 | -42.4 | -73.256 | -64.922 | -40.016 | -39.135 | -23.455 | -37.9 | -28.2 | -28.1 | -26.5 | -22.8 | -18.6 | -15.1 | -19.6 | -9.6 | -4.1 |
| EBITDA Ratio
| -0.292 | -0.956 | -0.026 | -0.236 | 0.326 | -0.103 | 0.041 | -0.134 | -0.196 | -0.13 | -0.351 | -0.509 | -0.61 | -0.351 | -0.226 | -0.049 | -0.467 | -2.618 | -0.837 | -0.91 | -1.316 | -0.61 | -0.854 | -0.15 | -0.906 | -0.694 | -0.997 | -1.358 | -1.985 | -2.386 | -1.248 | -2.494 | -1.81 | -2.05 |